AI-powered stock picks with a proven track record to beat the S&P 500.

This advancement positions CSPC as a significant player in addressing unmet medical needs in the oncology sector. For further insights into HK:1093 stock, check out TipRanks’ Stock Analysis page.

Overview: CSPC Innovation Pharmaceutical Co., Ltd. focuses on the research, development, production, and sales of biopharmaceuticals, APIs, and functional foods both in China and internationally ...

CSPC Pharmaceutical Group (CSPC) is a pharmaceutical company, which provides innovative, generic and bulk drugs. The company manufactures, research and markets medicines and pharmaceutical related ...

CSPC Pharmaceutical Group (HK:1093) has released an update. Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks Make smarter investments ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks CSPC Pharmaceutical Group has entered into an exclusive license agreement with BeiGene for the global ...

Drug regulators cleared the vaccine, developed by CSPC Pharmaceutical Group, for emergency use, the company said. China's labs have been trying to create an mRNA vaccine for years - the country ...